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ated with CLCN5 mutations. In addition, our study is the firstClinical and genetic studies of CLCN5 mutations in Japanese
to demonstrate the use of urinary sediment cells and renalfamilies with Dent’s disease.
tissue for the detection of CLCN5 transcript abnormalities.Background. Dent’s disease is an X-linked renal tubular
These results help to expand the spectrum of CLCN5 mutationsdisorder that is characterized by low molecular weight protein-
associated with Dent’s disease.uria, hypercalciuria, nephrolithiasis, and renal failure. The dis-
ease is caused by inactivation of a renal chloride channel gene,
CLCN5, that encodes a 746-amino acid protein with 12 to
13 transmembrane domains. The Japanese variant of Dent’s
Four disorders of hereditary hypercalciuric nephroli-disease has been observed to be less severe, and we have
thiasis that have been referred to as Dent’s disease,investigated two unrelated Japanese families for CLCN5 muta-
tions. X-linked recessive nephrolithiasis, X-linked recessive
Methods. Six patients from two unrelated families were stud- hypophosphatemic rickets, and the idiopathic low molec-
ied. Leukocyte DNA from probands was used with CLCN5-
ular weight proteinuria (LMWP) of Japanese childrenspecific primers for polymerase chain reaction (PCR) amplifi-
are associated with mutations of the X-linked renal-spe-cation of the coding region and exon-intron boundaries, and the
DNA sequences of the products were determined to identify cific voltage-gated chloride channel gene, CLCN5 [1, 2].
abnormalities in the gene. RNA extracted from the kidney, All four of these diseases have features in common, and
leukocytes, or urine sediments was used to characterize further they represent renal tubular disorders that are character-
the effects of the identified mutations.
ized by LMWP, hypercalciuria, nephrocalcinosis, neph-Results. b2-microglobulinuria was detected in five patients,
rolithiasis, and renal failure [3–5]. On the basis of pheno-hypercalciuria in two patients, nephrolithiasis in three patients
(2 of whom were females), and one 51-year-old man had renal typic similarities and the common genetic etiology, these
failure. Two novel CLCN5 mutations consisting of an a to g disorders are collectively referred to as Dent’s disease
transition at the invariant ag acceptor splice site of intron 5 [3, 6, 7]. Forty different CLCN5 mutations, consisting ofand an intragenic deletion that encompassed the region be-
nonsense, missense, acceptor splice site, donor splicetween intron 3 and intron 6 were identified. The acceptor splice
site, and insertional and deletional mutations, have beensite mutation led to the utilization of two alternative cryptic
splice sites in exon 6 that resulted in a frameshift or skipping reported in patients with Dent’s disease [1–3, 7–13]. The
of the exon 6. The deletional mutation, which resulted in a human CLCN5 gene, which is located on chromosome
loss of exons 4, 5, and 6, is predicted to lead to a loss of Xp11.22, has a 2238 bp coding region that consists of 11domains 1 through 4. Both mutations predict truncated chloride
exons, which span 25 to 30 kb of genomic DNA andchannels that are likely to result in a functional loss.
encode a 746 amino acid channel, referred to as CLC-5.Conclusions. The observations of renal failure in one male
and nephrolithiasis in two females represent important new CLCN5 belongs to the family of voltage-gated chloride
findings in this Japanese variant of Dent’s disease that is associ- channel genes (CLCN1-CLCN7, CLCKa, and CLCKb),
which have about 12 transmembrane domains [14, 15].
These chloride channels have importance in the controlKey words: gene mutation, nephrolithiasis, X-linked renal disease, pro-
teinuria, renal failure. of membrane excitability, transepithelial transport, and
cell volume [14, 15]. Heterologous expression of wild-
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type CLCN5 in Xenopus oocytes has revealed thatand in revised form February 16, 2000
Accepted for publication March 10, 2000 CLC-5 conducts chloride currents that are outwardly
rectifying and time independent, and similar expressionÓ 2000 by the International Society of Nephrology
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Table 1. Clinical and biochemical findings in Japanese patients with Dent’s disease
Family 1 2
Normal
Patient 1 2 3 4a 5 6 adult (child)
Age years 56 34 10 51 23 4
Age at diagnosis years 56 34 3 29 16 4
Sex F F M M F M
Serum
Cr mg/dL 1.1 0.7 0.5 9.5 0.6 0.3 M: 0.5–1.2, F: 0.4–0.9
(4–14 years old: 0.3–0.8)
Ca mg/dL NE 9.0 9.7 9.0 NE NE 9.0–10.6
P mg/dL NE 3.5 4.8 4.8 NE NE 3.8–5.6
Urine
b2-microglobulin lg/L 12,235 800 15,538 NE 1,284 27,669 ,250 (,320)
Protein mg/dL 137 12 100 270 14 129 ,15
Occult blood 31 2 1 1 2 2 —
Ca/Cr mg/mg 0.05 0.12 0.28 NE 0.08 0.35 ,0.20 (,0.25)
Osmolarity mOsm/L 586 NE 809 320 NE 576 .800
or specific gravity NE 1.030 NE NE 1.032 NE .1.025
Nephrolithiasis 1 2 2 1 1 2 —
CCr mL/min/1.73 m2 47 NE 137 3 NE 139 M ,50 years old: 78–134
M 50–60 years old: 55–107
F ,50 years old: 65–115
F 50–60 years old: 53–93
(4–14 years old: 65–150)
Abbreviations are: Cr, creatinine; Ca, calcium; P, phosphate; CCr, creatinine clearance; M, adult male; F, adult female. All values refer to those obtained on early
morning samples after an overnight fast. Signs are: 1, present; 2, absent; NE, not examined.
a Patient 4 had renal impairment (CCr 5 45 mL/min/1.73 m2) at the age of 42 years when he developed a thoracic carcinoid tumor. He was normotensive, and did
not have rickets or hydronephrosis. The tumor was resected, but the tumor relapsed 4 years later when he developed end-stage renal failure, while having a blood
pressure of 150/100 mm Hg.
of disease-associated CLC-5 mutants demonstrated mark- Mutational analysis of the CLCN5 gene
edly reduced or absent currents [1–3]. We have investi- Leukocyte DNA was extracted and used with CLCN5-
gated two additional Japanese families with Dent’s dis- specific primers for polymerase chain reaction (PCR)
ease for CLCN5 mutations and have explored the use amplification utilizing the previously described condi-
of urinary sediment cells and renal tissue for the detec- tions [2, 3, 7]. The DNA sequence of the PCR products
tion of abnormal CLCN5 transcripts. was determined by the use of Taq polymerase cycle se-
quencing and a semiautomated detection system (ABI
373A sequencer; Perkin Elmer Japan Applied Biosys-
METHODS tems Division, Japan) [2, 7, 11]. DNA sequence abnor-
malities were confirmed either by a reanalysis of addi-The study protocol was in accordance with the stan-
tional PCR products or by restriction endonucleasedards of the ethics committee at each hospital, and all
analysis of genomic PCR products obtained by the usepatient’s parents and adult patients gave informed con-
of the appropriate primers as described [2, 7, 11]. Insent after the purpose, nature, and potential risks of the
addition, DNA sequence abnormalities were also dem-study were explained to them.
onstrated to be absent as common polymorphisms in
the DNA obtained from 56 unrelated normal JapanesePatients
individuals (54 females and 2 males). Southern blot anal-
Six members of two unrelated Japanese families were ysis for the detection of deletions was performed as pre-
clinically and biochemically assessed for LMWP, renal viously described [1, 7] using the restriction endonucle-
function, hypercalciuria, and nephrolithiasis, as described ase EcoR I.
previously. All of the urinary measurements were per-
formed on early morning samples obtained with the pa- CLCN5 transcript analysis
tients fasting and after overnight water deprivation. Uri- Total RNA was extracted from a diagnostic renal
nary calcium-to-creatinine ratios (Ca/Cr) .0.25 mg/mg biopsy obtained after informed consent from patient 3,
and .0.20 mg/mg in children and adults, respectively, leukocytes (both patients), and urine sediments from
were taken to be elevated. The details of the six affected patient 6 (Table 1) by the acid guanidine thiocyanate-
members from these two families are summarized in phenol-chloroform method [16, 17] and was used with
random primers to generate cDNAs. Urine sedimentsTable 1.
Fig. 2. Analysis of aberrant CLCN5 transcripts due to acceptor splice
site mutation. CLCN5 transcript analysis in patient 3 (Table 1) and a
normal individual revealed only one 326 bp band in the leukocytes
(lane 1) and kidney (lane 3) from the control, but two products of 294
and 120 bp from the leukocytes of patient 3 (lane 2), and three products
of 294, 238, and 120 bp from the kidney of patient 3 (lane 4). The
locations of the bands for the standard size marker in the form of øX174
Hae III (Fig. 1) digestion is indicated on the left (M). These findings
indicate that three abnormal CLCN5 transcripts (Fig. 3) result from
the acceptor splice site mutation.
were obtained by centrifugation at 1500 r.p.m. for 10
minutes from 100 mL of early morning urine. Primers
[sense 59-CTCCTATTTGCCTTCCTTGCCGTA-39 (pri-
Fig. 1. Detection of mutation in the acceptor splice site in intron 5 in mer 1; nt. 733 to 755) and antisense 59-CCAAAGGCTA
family 1 by restriction enzyme analysis. DNA sequence analysis of the
CAGATACACCAGCT-39 (primer 2; nt. 1035 to 1058)]affected male (patient 3; Table 1) revealed an a to g transition of the
22 bp position of the consensus acceptor splice site in intron 5 (i). specific to exons 5 and 7, respectively, were used to
This mutation resulted in the loss of a Pst I restriction enzyme site obtained partial cDNAs from the RNA obtained from
(CTGCA/G), which facilitated its detection. PCR amplification and Pst
the kidney of patient 3 and were subcloned into TAI digestion (ii) would result in two products of 240 bp and 54 bp (data
not shown) from the normal sequence (N) but only one product of 294 vector pGEM (pGEM-T and pGEM-T Easy Vector Sys-
bp from the mutant sequence (3), as is illustrated in the restriction map tems, Technical Manual; Promega Corporation, Madi-
(iii). The mother (2) and grandmother (1) are heterozygous for the
son, WI, USA). After transformation in E. coli HB101,wild-type and mutant alleles. This acceptor splice site mutation was not
present in 56 unrelated, normal (N), Japanese individuals (54 females 15 ampicillin-resistant transformed colonies were se-
and 2 males), thereby indicating that it is not a common DNA sequence lected and incubated in a 1.5 mL medium at 378C. After
polymorphism. Individuals shown are male (square), female (circle), un-
the isolation of recombinant plasmid DNA from 15 colo-affected (open), carrier (half filled), and affected (filled). The standard-
sized marker in the form of øX174 Hae III digestion is indicated as M. nies, the original PCR products were amplified with plas-
c
Fig. 3. DNA sequence analysis of the three abnormal CLCN5 transcript resulting from the acceptor splice site mutation in intron 5. DNA sequence
analysis of the CLCN5 transcripts from the kidney of patient 3 (Table 1 and Fig. 1) revealed three abnormal splice variants, which consisted of
exon 5 spliced to nt. 840 of exon 6 (type 1 abnormal splicing) instead of nt. 808 as in the control; exon 5 spliced to nt. 896 of exon 6 (type 2); and
exon 5 spliced to exon 7 indicating skipping of exon 6 (type 3). Of the 15 clones analyzed, the number of clones with types 1, 2, and 3 abnormal
splicing was 5, 6, and 4, respectively.
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Fig. 5. Analysis of aberrant CLCN5 transcripts caused by intragenic
deletion of CLCN5. A 1.4 kb single band was identified in the control
kidney (lane 1), control leukocytes (data not shown), and control urine
sediment cells (data not shown), whereas a single 0.9 kb band was
identified in urine sediments (lane 2) and leukocytes (lane 3) from
patient 6. These findings suggested a 0.6 kb deletion in the CLCN5
cDNA from patient 6. The standard-sized marker in the form of lambda
DNA-HindIII digest is indicated as M.
mid-specific primer M3, and the amplified 15 PCR prod-
ucts were sequenced. The DNA sequence of the PCR
product from a control kidney was also determined. The
PCR products from the kidney and leukocytes of patient 3
and a control individual were subjected to agarose gel
electrophoresis, transferred to nylon filter, hybridized with
32P-labeled primer 1 and exposed to x-ray film at 2708C.
Primers [sense 59-GTCGTACAATGGTGGAGGAAT
AGG-39 (primer 3; nt. 251 to 275) and antisense 59-CAT
GCTAGGGATAAAGAGGCCAGA-39 (primer 4; nt.
1645 to 1668)] specific to exons 2 and 9, respectively,
were used to obtain partial cDNAs from the RNA ob-
tained from the urine sediment cells and leukocytes of
patient 6 and a control individual, and the DNA se-
quences of the PCR products were determined. This
DNA sequence analysis was performed with primers
[sense 59-AGTGATGCTTTTTCCGGCTGGTTGT-39
(primer 5; nt. 447 to 469) and antisense 59-CCAAAGGCFig. 4. Southern blot analysis of leukocyte DNA from family 2 with
TACAGATACACCAGCT-39 (primer 6; nt. 1035 toDent’s disease. EcoR I restriction enzyme analysis and the use of the
whole human CLC-5 cDNA as a probe revealed five bands (12, 7.7, 1058)] specific to exons 3 and 7, respectively. The PCR
4.4, 2.3, and 0.8 kb) in the control (N) and the mother (4). However, products from patient 6 and a control individual were
the 7.7 kb band in the two male patients [grandfather (4) and the patient
subjected to agarose gel electrophoresis, transferred to(6)]. Individuals shown are male (square), female (circle), unaffected
(open), carrier (half filled), and affected (filled). The standard size nylon filter, hybridized with 32P-labeled primer 5 and
marker in the form of lambda DNA-HindIII digest is indicated as M. exposed to x-ray film at 2708C [1, 7].
These results are consistent with an intragenic deletion of CLCN5,
and the lack of PCR products using primers specific for exons 4, 5,
and 6 suggested that this deletion encompassed a region from introns RESULTS3 through 6.
The six patients (3 males and 3 females) had ages
ranging from 3 to 56 years (Table 1). b2-microglobu-
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Fig. 6. DNA sequence of abnormal CLCN5 transcript caused by the microdeletion. DNA sequence analysis of the 0.9 kb CLCN5 transcript (Fig.
5) from patient 6 revealed that exon 3 was spliced to exon 7. Thus, the 0.6 kb difference between the control and patient is due to an absence of
exons 4, 5, and 6. This would result in a frameshift with 25 missense amino acids followed by a termination codon (TGA).
linuria was documented in five patients, hypercalciuria to skipping of exon 6 (Fig. 3). All of these splice variants
in two patients, nephrolithiasis in three patients, two of lead to frameshifts that if translated would result in trun-
whom were female, and end-stage renal failure in one cated CLC-5 channels that would be inactive.
male. Nephrolithiasis has been previously reported in DNA sequence analysis of the coding region and exon-
two females with Dent’s disease [4, 10], and the observa- intron boundaries of exons 2, 3, 7, 8, 9, 10, and 11 of the
tion of renal insufficiency in the 56-year-old female CLCN5 gene from patient 6, who is an affected male in
(patient 1; Table 1) and end-stage renal failure in the family 2 (Table 1), revealed no abnormalities, but PCR
51-year-old man (patient 4; Table 1) indicated that the products were repeatedly not obtained from exons 4, 5,
Japanese variant is clinically similar to the other variants and 6, suggesting a possible intragenic deletion. This was
reported of Dent’s disease. investigated by Southern blot analysis of genomic DNA
DNA sequence analysis of the entire 2238 bp coding (Fig. 4), which revealed an absence of a 7.7 kb EcoR I
region and exon-intron boundaries of the CLCN5 gene fragment in patients 4 and 6. The effects of this likely
from patient 3 in family 1 revealed an a to g transition microdeletion on CLCN5 transcripts were studied by
at position 22 bp of the consensus acceptor splice site the use of RNA obtained from urine sediment cells and
sequence of intron 5 (Fig. 1). This acceptor splice site leukocytes (Fig. 5). This revealed a 1.4 kb CLCN5 tran-
mutation resulted in an alteration of a Pst I restriction script from the control kidney and a 0.9 kb transcript
enzyme site, which facilitated its confirmation and cose- from the patient’s urine sediment cells and leukocytes.
gregation with the disorder in family 1. The absence of DNA sequence analysis of the abnormal 0.9 kb CLCN5
the DNA sequence abnormality in 110 alleles from 56 transcript revealed that exon 3 was spliced to exon 7 (Fig.
unrelated, normal Japanese individuals (54 females and 2 6). These findings are consistent with the observation of
males) established that this DNA sequence abnormality an intragenic microdeletion resulting in a loss of exons
was a mutation and not a polymorphism that would be 4, 5, and 6 (Fig. 6). This deletion does not alter the
expected to occur in more than 1% of the population. encoded guanine (GGT) at codon 69 but results in a
The effects of this acceptor splice site mutation on frameshift of the subsequent 25 amino acids in exon 7
CLCN5 transcripts were studied by the use of RNA that is followed by a premature termination codon
obtained from leukocytes and kidneys (Fig. 2). This re- (TGA), and this, if translated, is likely to result in a
vealed three abnormal CLCN5 transcripts from the pa- truncated CLC-5 with a resulting loss of function.
tient’s kidney and two abnormal transcripts from the
patient’s leukocytes (Fig. 2). DNA sequence analysis of
DISCUSSIONthese abnormal transcripts revealed that they resulted
Our clinical studies of Japanese patients with Dent’sfrom the use of either cryptic acceptor splice sites in
exon 6 or the acceptor splice site in intron 6 that lead disease provide further observations regarding the pro-
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gression of this renal disorder. The Japanese variant of been reported in patients with Dent’s disease [1, 9], and
Dent’s disease has been reported [5, 18–20] to be associ- all of these mutations are likely to lead to an inactivated
ated with a milder phenotype than the British [4] and CLC-5 channel. Our use of cells from the urinary sedi-
North American variants [21]. This may have stemmed ment to assess the effect of the intragenic deletion in
partly from the different ages at which the patients were family 2 (Fig. 5 and 6) demonstrates the value of this
studied; for example, the Japanese patients were mainly method and opens the possibility that such mutational
children, whereas the British and North American pa- analysis of CLCN5 may be performed in urinary sedi-
tients consisted of mainly adults. Our observations of ment cells in such patients from whom blood samples
renal impairment in a 51-year-old man (patient 4; Table may not be readily available. Our studies have helped
1) who had renal insufficiency at age 42 years and who to characterize further the clinical and genetic manifesta-
developed end-stage renal failure at the age of 46 years tions of the Japanese variant of Dent’s disease.
indicate that the progression of the Dent’s disease in the
Japanese variants could be similar to that observed in ACKNOWLEDGMENTS
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